Theme 09 - Clinical Trials and Trial Design

Acknowledgments

Medical writing support was provided by Anubhav Mehra and reviewed by Allen Amedume, of Sanofi.

Acknowledgements

We would like to thank the participants, their family, clinical trial staff, and PIs for taking part in this study.

Acknowledgments

We would like to thank patients for taking part in the study.

Acknowledgments

We thank those with ALS participating in the REFINE-ALS study, and the REFINE-ALS Site Investigators. The authors thank Sally Nelson, MS, PhD, a former employee of Mitsubishi Tanabe Pharma America, Inc. who contributed to the analysis of this study. The authors thank Irene Brody, VMD, PhD of p-value communications, Cedar Knolls, NJ, USA, for providing medical writing support. Editorial support was also provided by p-value communications.

Acknowledgements

We thank trial participants, their caregivers, and COURAGE-ALS sites and team members.

Acknowledgements

EXPERTS-ALS is being presented on behalf of a large consortium bringing together 11 UK MND Care Centres, the scientific expertise from within their associated NIHR Biomedical Research Centres (BRCs) and Dementia Research Institute (DRI) centres.